Summit X LLC’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-7,328
Closed -$691K 217
2023
Q2
$691K Buy
7,328
+83
+1% +$7.83K 0.17% 122
2023
Q1
$599K Sell
7,245
-315
-4% -$26.1K 0.15% 133
2022
Q4
$719K Buy
7,560
+90
+1% +$8.56K 0.21% 102
2022
Q3
$619K Sell
7,470
-90
-1% -$7.46K 0.18% 123
2022
Q2
$721K Sell
7,560
-150
-2% -$14.3K 0.21% 103
2022
Q1
$905K Sell
7,710
-3,235
-30% -$380K 0.22% 94
2021
Q4
$1.42M Buy
10,945
+70
+0.6% +$9.05K 0.33% 70
2021
Q3
$1.23M Sell
10,875
-15
-0.1% -$1.7K 0.31% 73
2021
Q2
$1.13M Sell
10,890
-205
-2% -$21.2K 0.28% 86
2021
Q1
$928K Sell
11,095
-300
-3% -$25.1K 0.25% 96
2020
Q4
$1.04M Sell
11,395
-310
-3% -$28.2K 0.31% 79
2020
Q3
$3.59K Buy
11,705
+3,395
+41% +$1.04K 0.06% 144
2020
Q2
$574K Buy
8,310
+210
+3% +$14.5K 0.21% 108
2020
Q1
$513K Sell
8,100
-495
-6% -$31.4K 0.24% 99
2019
Q4
$665K Sell
8,595
-2,175
-20% -$168K 0.25% 104
2019
Q3
$789K Sell
10,770
-30
-0.3% -$2.2K 0.32% 87
2019
Q2
$662K Buy
10,800
+30
+0.3% +$1.84K 0.27% 97
2019
Q1
$690K Buy
10,770
+495
+5% +$31.7K 0.3% 90
2018
Q4
$525K Buy
10,275
+90
+0.9% +$4.6K 0.3% 94
2018
Q3
$592K Buy
10,185
+90
+0.9% +$5.23K 0.29% 87
2018
Q2
$488K Sell
10,095
-702
-7% -$33.9K 0.27% 99
2018
Q1
$506K Buy
10,797
+192
+2% +$9K 0.3% 89
2017
Q4
$405K Buy
10,605
+150
+1% +$5.73K 0.26% 119
2017
Q3
$377K Buy
10,455
+60
+0.6% +$2.16K 0.25% 117
2017
Q2
$411K Buy
+10,395
New +$411K 0.29% 105